Janus Henderson Group PLC lifted its position in Tabula Rasa HealthCare Inc (NASDAQ:TRHC) by 119.0% during the third quarter, Holdings Channel reports. The institutional investor owned 10,674 shares of the company’s stock after purchasing an additional 5,799 shares during the period. Janus Henderson Group PLC’s holdings in Tabula Rasa HealthCare were worth $867,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds have also recently added to or reduced their stakes in the company. Mount Yale Investment Advisors LLC purchased a new position in shares of Tabula Rasa HealthCare in the 2nd quarter worth $111,000. Meadow Creek Investment Management LLC purchased a new position in Tabula Rasa HealthCare during the second quarter valued at $115,000. Envestnet Asset Management Inc. purchased a new position in Tabula Rasa HealthCare during the second quarter valued at $130,000. Pinebridge Investments L.P. purchased a new position in Tabula Rasa HealthCare during the second quarter valued at $181,000. Finally, Teacher Retirement System of Texas purchased a new position in Tabula Rasa HealthCare during the second quarter valued at $207,000. Hedge funds and other institutional investors own 74.88% of the company’s stock.

In other news, CEO Calvin H. Knowlton sold 8,000 shares of the business’s stock in a transaction dated Monday, October 8th. The stock was sold at an average price of $74.22, for a total value of $593,760.00. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, President Orsula V. Knowlton acquired 7,500 shares of the stock in a transaction dated Monday, November 12th. The stock was acquired at an average price of $65.00 per share, for a total transaction of $487,500.00. The disclosure for this purchase can be found here. Insiders sold 59,733 shares of company stock worth $4,394,172 over the last 90 days. Company insiders own 14.00% of the company’s stock.

Several research firms recently weighed in on TRHC. Stifel Nicolaus began coverage on Tabula Rasa HealthCare in a research report on Tuesday, September 11th. They set a “hold” rating and a $95.00 target price on the stock. Cantor Fitzgerald began coverage on Tabula Rasa HealthCare in a research report on Thursday, September 6th. They set an “overweight” rating and a $99.00 target price on the stock. Zacks Investment Research upgraded Tabula Rasa HealthCare from a “sell” rating to a “hold” rating in a research report on Thursday, December 6th. Oppenheimer lifted their target price on Tabula Rasa HealthCare from $65.00 to $86.00 and gave the company an “outperform” rating in a research report on Thursday, August 23rd. Finally, BidaskClub upgraded Tabula Rasa HealthCare from a “hold” rating to a “buy” rating in a research report on Wednesday, November 28th. Two research analysts have rated the stock with a hold rating and eleven have given a buy rating to the company’s stock. The company has a consensus rating of “Buy” and a consensus price target of $82.50.

Shares of Tabula Rasa HealthCare stock opened at $70.05 on Friday. Tabula Rasa HealthCare Inc has a 52 week low of $27.40 and a 52 week high of $91.16. The stock has a market capitalization of $1.55 billion, a PE ratio of -1,751.25, a price-to-earnings-growth ratio of 7.20 and a beta of 2.53. The company has a current ratio of 0.49, a quick ratio of 0.46 and a debt-to-equity ratio of 0.28.

Tabula Rasa HealthCare (NASDAQ:TRHC) last announced its quarterly earnings data on Tuesday, November 6th. The company reported $0.26 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.19 by $0.07. Tabula Rasa HealthCare had a positive return on equity of 7.63% and a negative net margin of 13.49%. The business had revenue of $54.42 million for the quarter, compared to the consensus estimate of $52.87 million. During the same period in the previous year, the business earned $0.08 earnings per share. The business’s revenue was up 66.3% on a year-over-year basis. On average, equities research analysts anticipate that Tabula Rasa HealthCare Inc will post 0.42 EPS for the current fiscal year.

COPYRIGHT VIOLATION NOTICE: This report was originally reported by Watch List News and is owned by of Watch List News. If you are viewing this report on another domain, it was copied illegally and republished in violation of US & international trademark and copyright laws. The legal version of this report can be accessed at https://www.watchlistnews.com/janus-henderson-group-plc-grows-stake-in-tabula-rasa-healthcare-inc-trhc/2689615.html.

Tabula Rasa HealthCare Profile

Tabula Rasa HealthCare, Inc operates as a healthcare technology company in the United States. It offers medication risk management, pharmacy cost management, and medicare risk adjustment services. The company offers its technology-enabled products and services to prescribers, pharmacists, and healthcare organizations for medication risk management and risk adjustment.

Featured Article: Intrinsic Value and Stock Selection

Want to see what other hedge funds are holding TRHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Tabula Rasa HealthCare Inc (NASDAQ:TRHC).

Institutional Ownership by Quarter for Tabula Rasa HealthCare (NASDAQ:TRHC)

Receive News & Ratings for Tabula Rasa HealthCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tabula Rasa HealthCare and related companies with MarketBeat.com's FREE daily email newsletter.